4/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: October 2, 2018
Period of Report: January 30, 2014
Accession Number: 0001177648-18-000037

View Document ↗ View on SEC.gov ↗